Evaluation of Efficacy and Safety of Relapsed and Refractory Multiple Myeloma Patients Treated with Pomalidomide

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2021
This article has no abstract
Epistemonikos ID: c6b4fb082449b24744a3c1092e7cafd3497705bb
First added on: Apr 08, 2025